you're reading...
Autoimmune Diseases, Dermatomyositis, Methotrexate

FDA Update on U.S. Methotrexate Shortage

Methotrexate is one of the medications my husband takes every week to manage his autoimmune disease, dermatomyositis. For the past 6 weeks, the shortage of injectable methotrexate has forced him to switch to the oral form. For some reason, these tiny pills make him feel nauseous, unlike the injection. It’s the same dosage, so I’m not sure why. Anyway, we are waiting and waiting for the manufacturers to step up production. I checked the FDA website today. As of their last update on April 12th, limited supplies are slowly becoming available.

View the FDA site here.

 

 

Advertisements

Discussion

One thought on “FDA Update on U.S. Methotrexate Shortage

  1. I have been taking the methotrexate for 4 years. I no longer have insurance. I found out the manufacturer has went up in cost on the medicine. 30 pills now cost $100 without insurance.

    Posted by joyce | April 12, 2013, 12:51 pm

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: